Subtopic Deep Dive

← Health Systems, Economic Evaluations, Quality of Life

Health Technology Assessment Methods
Research Guide

What is Health Technology Assessment Methods?

Health Technology Assessment Methods comprise standardized methodologies for evaluating the clinical, economic, and social impacts of health technologies to inform reimbursement and policy decisions.

These methods include cost-effectiveness analysis, probabilistic sensitivity analysis, and reporting standards like CHEERS. Key guidelines emphasize transparent reporting from multiple perspectives (Sanders et al., 2016; Husereau et al., 2013). Over 2,800 citations document recommendations for cost-effectiveness analyses (Sanders et al., 2016).

Curated Papers

Key Challenges

Why It Matters

HTA methods guide reimbursement decisions for new drugs and devices, optimizing healthcare budgets. Sanders et al. (2016) recommend dual-perspective analyses to improve decision-making reliability. Husereau et al. (2013) CHEERS standards ensure reproducible economic evaluations, reducing adoption of ineffective technologies. Guyot et al. (2012) enable meta-analyses from Kaplan-Meier curves, enhancing real-world evidence integration.

Key Research Challenges

Probabilistic Sensitivity Analysis

Quantifying parameter uncertainty in cost-effectiveness models remains complex. Sanders et al. (2016) highlight needs for improved reference case perspectives. Accurate uncertainty propagation affects reimbursement thresholds.

Real-World Evidence Integration

Incorporating non-RCT data into HTA models faces validity challenges. Guyot et al. (2012) reconstruct survival data from curves for meta-analysis. Standardization lags behind RCT evidence.

Transparent Reporting Standards

Inconsistent reporting hinders reproducibility in economic evaluations. Husereau et al. (2013) provide CHEERS guidelines with 1975 citations. Compliance varies across journals.

Essential Papers

CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials

David Moher, Sally Hopewell, Kenneth F. Schulz et al. · 2010 · BMJ · 8.7K citations

Overwhelming evidence shows the quality of reporting of randomised controlled trials (RCTs) is not optimal. Without transparent reporting, readers cannot judge the reliability and validity of trial...

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof, Stefano Benussi, Dipak Kotecha et al. · 2016 · EP Europace · 6.5K citations

peer reviewed

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Frank L.J. Visseren, François Mach, Yvo M. Smulders et al. · 2021 · European Heart Journal · 5.7K citations

International audience

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Francesco Cosentino, Peter J Grant, Victor Aboyans et al. · 2019 · European Heart Journal · 4.7K citations

2019 ESC Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD

High-quality health systems in the Sustainable Development Goals era: time for a revolution

Margaret E. Kruk, Anna Gage, Catherine Arsenault et al. · 2018 · The Lancet Global Health · 3.5K citations

<p>Although health outcomes have improved in low-income and middle-income countries (LMICs) in the past several decades, a new reality is at hand. Changing health needs, growing public expect...

Forecasting the Future of Cardiovascular Disease in the United States

Paul A. Heidenreich, Justin G. Trogdon, Olga Khavjou et al. · 2011 · Circulation · 3.2K citations

Background— Cardiovascular disease (CVD) is the leading cause of death in the United States and is responsible for 17% of national health expenditures. As the population ages, these costs are expec...

2023 Alzheimer's disease facts and figures

V Villemagne, S Burnham, P Bourgeat et al. · 2023 · Alzheimer s & Dementia · 2.8K citations

Abstract This article describes the public health impact of Alzheimer's disease, including prevalence and incidence, mortality and morbidity, use and costs of care, and the overall impact on family...

Reading Guide

Foundational Papers

Start with Husereau et al. (2013) CHEERS for reporting standards (1975 citations), then Sanders et al. (2016) for cost-effectiveness practices, followed by Guyot et al. (2012) for data reconstruction tools.

Recent Advances

Sanders et al. (2016) updates reference cases; Kruk et al. (2018) links HTA to high-quality systems.

Core Methods

Cost-effectiveness from societal/healthcare perspectives (Sanders et al., 2016); CHEERS elaboration (Husereau et al., 2013); Kaplan-Meier reconstruction algorithm (Guyot et al., 2012).

How PapersFlow Helps You Research Health Technology Assessment Methods

Discover & Search

Research Agent uses searchPapers and citationGraph to map HTA literature from Sanders et al. (2016, 2812 citations) to Husereau et al. (2013). exaSearch uncovers guidelines like CHEERS; findSimilarPapers links to Moher et al. (2010) CONSORT standards.

Analyze & Verify

Analysis Agent applies readPaperContent to extract methods from Sanders et al. (2016), then verifyResponse with CoVe for claim validation. runPythonAnalysis reconstructs Kaplan-Meier data from Guyot et al. (2012) using NumPy/pandas; GRADE grading assesses evidence quality in cost-effectiveness recommendations.

Synthesize & Write

Synthesis Agent detects gaps in probabilistic sensitivity analysis across papers, flagging contradictions. Writing Agent uses latexEditText, latexSyncCitations for CHEERS-compliant reports, latexCompile for publication-ready outputs, and exportMermaid for decision tree diagrams.

Use Cases

"Reconstruct survival curves from published HTA papers for meta-analysis."

Research Agent → searchPapers(Guyot et al. 2012) → Analysis Agent → runPythonAnalysis(pandas plot KM curves) → matplotlib figure of reconstructed data.

"Draft CHEERS-compliant HTA report on cost-effectiveness."

Synthesis Agent → gap detection(Husereau et al. 2013) → Writing Agent → latexEditText(abstract) → latexSyncCitations(Sanders 2016) → latexCompile(PDF report).

"Find GitHub code for probabilistic sensitivity analysis in HTA."

Research Agent → paperExtractUrls(Guyot 2012) → Code Discovery → paperFindGithubRepo → githubRepoInspect(PSOA Monte Carlo scripts) → runPythonAnalysis(test code).

Automated Workflows

Deep Research workflow conducts systematic reviews of 50+ HTA papers: searchPapers → citationGraph(Sanders 2016 cluster) → structured GRADE-graded report. DeepScan applies 7-step analysis with CoVe checkpoints to verify Husereau et al. (2013) CHEERS compliance. Theorizer generates HTA method extensions from Grimshaw et al. (2012) knowledge translation.

Try Doxa for Health Technology Assessment Methods Research

Frequently Asked Questions

What defines Health Technology Assessment Methods?

HTA methods standardize evaluations of health technologies' clinical, economic, and social impacts for policy decisions, including cost-effectiveness and sensitivity analyses.

What are core methods in HTA?

Methods include cost-effectiveness analysis from dual perspectives (Sanders et al., 2016), CHEERS reporting (Husereau et al., 2013), and survival data reconstruction (Guyot et al., 2012).

What are key papers?

Sanders et al. (2016, 2812 citations) on cost-effectiveness recommendations; Husereau et al. (2013, 1975 citations) on CHEERS; Guyot et al. (2012, 2333 citations) on Kaplan-Meier reconstruction.

What open problems exist?

Challenges include standardizing real-world evidence integration and probabilistic uncertainty modeling beyond RCTs (Sanders et al., 2016; Guyot et al., 2012).